Market Cap
$367.98B
$132.58B
Country
United States
United States
Employees
131.90K
88.00K
Industry
🇺🇸 United States
🇺🇸 United States
Outstanding Shares
2.41B
5.69B
Comparison Verdict
About Johnson & Johnson and Pfizer
Johnson & Johnson (JNJ) and Pfizer (PFE) are both prominent companies in their respective sectors. This comparison helps investors understand the key differences between these two stocks.
Key Takeaways
- Market Cap: Johnson & Johnson ($367.98B) vs Pfizer ($132.58B)
- Valuation: Johnson & Johnson has a P/E ratio of $16.87 vs $16.76 for Pfizer
- Dividend Yield: Johnson & Johnson offers 2.43% vs 7.30% from Pfizer
- Assets: Johnson & Johnson has $193.67B in total assets compared to $213.40B for Pfizer
- 1-Year Performance: Johnson & Johnson gained 1.53% vs gain of 0.23% for Pfizer
- Outstanding Shares: Johnson & Johnson has 2.41B shares vs 5.69B for Pfizer